| Symbol | SRRK |
|---|---|
| Name | SCHOLAR ROCK HOLDING CORP |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biological Products, (No Diagnostic Substances) |
| Address | 301 BINNEY STREET, CAMBRIDGE, MA 02142 |
| Telephone | 857-259-3860 |
| Fax | — |
| — | |
| Website | https://www.scholarrock.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001727196 |
| Description | Scholar Rock Holding Corp is a biopharmaceutical company. It is engaged in the discovery and development of innovative medicines for the treatment of serious diseases including neuromuscular disorders, cancer, fibrosis, and anemia. Geographically, the company primarily operates in the United States. The companys lead product candidate is SRK-015 which is a highly selective, fully human, monoclonal antibody, with a mechanism of action that results in inhibition of the activation of the growth factor, myostatin, in skeletal muscle. Additional info from NASDAQ: |
Scholar Rock Provides Update on Global Apitegromab Regulatory Progress Across U.S., Europe, and Japan
Read moreScholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read moreNew Form SCHEDULE 13G/A - Scholar Rock Holding Corp <b>Filed:</b> 2026-08-13 <b>AccNo:</b> 0002005369-26-000045 <b>Size:</b> 13 KB
Read moreScholar Rock Announces FDA Review of Apitegromab Biologics License Application (BLA) for Spinal Muscular Atrophy (SMA) to Progress with Second Fill-Finish Facility; Approval Decision Anticipated by September 30, 2026 Action Date
Read moreScholar Rock Reports Second Quarter 2026 Financial Results and Recent Business Highlights
Read moreScholar Rock to Present at the Canaccord Genuity 46th Annual Growth Conference
Read moreKuehn Law Encourages Investors of Scholar Rock Holding Corp to Contact Law Firm
Read moreScholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read moreFLIER JEFFREY S. 🔴 sold 3.1K shares of Scholar Rock Holding Corp (SRRK) at $54.88 Transaction Date: Jul 01, 2026 | Filing ID: 296252
Read more